Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00941668Phase 4Completed
Phase 4, randomised, double-blind trial of red blood cells in gingivitis (2 arms), sponsored by Colgate-Palmolive. Primary endpoints: Interleukin-1 at 4 weeks and Interleukin-6 at 4 weeks. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00941668.